Pfizer Could Year-End Target Hit on 2-to-1 Trial Payoff
Pfizer stock climbs as analysts weigh a pivotal prostate cancer trial. A Guggenheim bull case sees a $36 target by ye...
Determine which no fee travel card is better suited for you. Make the right choice for your travel goals and preferences.
22,493 articlesPfizer stock climbs as analysts weigh a pivotal prostate cancer trial. A Guggenheim bull case sees a $36 target by ye...
A recently launched XRP-focused ETF aims to deliver 3% monthly income by selling XRP call options, blending crypto ex...
Henry Hub natural gas vaulted to $7.72 in January before tumbling to $3.62 in February, forcing traders to pick sides...
As Cardano prepares to roll out its Midnight privacy network this week, the cardano shorts spike highest reading sinc...
Bitcoin and XRP lead the 2026 debate on how to deploy $1,000 in crypto, with macro momentum and policy shifts potenti...